.jpg&height=390.053)
The Santa Fe Fellows Workshop on Metabolic Bone Diseases is a two-day preceptorial for fellows. It will precede the 24th Annual Santa Fe Bone Symposium August 2-3, under the direction of the Osteoporosis Foundation of New Mexico. Drs. Michael McClung, John Bilezikian, and Michael Lewiecki lead the Fellows’ workshop which covers a broad spectrum of topics, including basic principles of bone metabolism, fracture risk assessment, an update of therapeutic approaches to osteoporosis, new guidelines for evaluation and therapy of primary hyperparathyroidism and hypoparathyroidism, as well as rare skeletal disorders such as hypophosphatasia, hypophosphatemia, and osteogenesis imperfecta. Faculty are internationally recognized in their field. Fellows are encouraged to submit an abstract to be presented at the Workshop. Four fellows will be selected to give oral presentations of their abstracts during the Santa Fe Bone Symposium.
Program Format:
The two-day interactive preceptorial features seventeen didactic lectures, four open discussion sessions for fellows and faculty to delve further into the presented topics, and fellow abstract presentations. Breakfast, lunch, and breaks will be provided each day. All fellows who participate in the workshop are invited attend the 24th Annual Santa Fe Bone Symposium August 2-3, 2024, in person or remotely, with complimentary registration due to a scholarship from the Osteoporosis Foundation of New Mexico.
2023 Faculty:
The faculty’s expertise extends to all facets of our field. This includes bone cell biology, bone biomechanics, histomorphometry of bone, and mechanisms of calciotropic hormone action. Their insights into the latest diagnostic and therapeutic approaches to osteoporosis, to other common and to rare metabolic bone diseases are at the forefront of the field, and in many instances, have been defined by their efforts.
- Laura Bachrach, MD, Professor Emeritus, Stanford University School of Medicine, Stanford, California
- John P. Bilezikian, MD, PhD (hon), Silberberg Professor of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York
- Steven T. Harris, MD, FACP, FASBMR, Clinical Professor of Medicine, University of California, San Francisco
- E. Michael Lewiecki, MD, FACP, FACE, Director, New Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico
- Michael R. McClung, MD, Founding Director, Oregon Osteoporosis Center, Portland, Oregon
- Andrea Singer, MD, FACP, CCD, Associate Professor and Chief, Division of Women’s Primary Care and Directory of Bone Densitometry, Department of Obstetrics and Gynecology, Georgetown University; Chief Medical Officer, National Osteoporosis Foundation, Washington, D.C
- Nelson Watts, MD, Director of Osteoporosis and Bone Health Services, Mercy Health, Cincinnati, Ohio
.jpeg&height=213)
Eligibility:Directors of Postdoctoral Subspecialty Training Programs for MDs are invited to select individuals from their programs who meet the criteria and whose education would be enhanced by participating in this Workshop. The trainees can be from any subspecialties that deal with skeletal health (i.e., endocrinology, rheumatology, orthopedics, geriatrics, women’s health, etc.). The MD must be in an accredited, relevant specialty training program (1st, 2nd, or 3rd year)
Selected fellows will be notified by the end of May. They will receive travel support for their flight, local airport ground transportation from ABQ, and three nights lodging at the event hotel when booked by EFF.
Santa Fe Fellows Workshop 2023
Educational Support:This educational activity was supported by unrestricted educational grants from: Alexion, Amgen, Amolyt Pharma, Ascendis Pharma, and Radius.